Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT01055587 Completed - Second Degree Burn Clinical Trials

Diagnostic of Infections Following Major Abdominal Surgery and Burn Injury

Earlygnost
Start date: September 2009
Phase: N/A
Study type: Observational

This study was designed to investigate, if new biomarkers may improve the early diagnostic of infections following major abdominal surgery and severe burn injuries.

NCT ID: NCT01054690 Completed - Clinical trials for Urinary Tract Infection

Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)

Start date: October 2008
Phase: N/A
Study type: Interventional

This study is a single blinded (Outcome Assessors), multicenter randomized controlled study designed to investigate if a silver alloyed urinary catheter with antibacterial properties can reduce the incidence of catheter acquired urinary tract infections in patients undergoing elective surgery. Patients requiring urinary catheterization will be randomized into two groups and receive either the silver alloyed catheter (test) or a silicone catheter (control).

NCT ID: NCT01054677 Completed - Clinical trials for Urinary Tract Infections

Swedish Antibiotic Nursing Home Trial

SANT
Start date: n/a
Phase: N/A
Study type: Interventional

Main aim and objective The aim was to present the treatment of infectious diseases in elderly, especially in nursing homes and further to evaluate the effect of an intervention package aiming at improving treatment with antibiotics in Swedish nursing homes Specific objectives - Present the treatment patterns regarding infectious diseases, including gender aspects in elderly, especially in nursing homes. - Through focus group discussions elucidate the decision making process in nursing homes and target the intervention. - Based on the above information develop an educational intervention to contribute to the improvement of the prescribing of antibiotics in nursing homes - Evaluate the effect of the intervention on quality of prescribing, knowledge and attitudes in relation to available guidelines

NCT ID: NCT01054638 Completed - Clinical trials for Cardiovascular Disease

HIV Treatment and CVD Events

Start date: March 2009
Phase: N/A
Study type: Observational

Cardiovascular disease (CVD) has been associated with HIV infection. However, it is uncertain whether increased CVD rates are associated with HIV-related factors (e.g., HIV-infection or highly active antiretroviral therapy (HAART) may worsen dyslipidemia) or reflect differences in the prevalence of underlying risk factors for CVD. Furthermore, the association between initiation and duration of HAART exposure and CVD risk, including which specific drugs within the HAART classes may contribute to the increased risk, is unknown. The primary objectives of the study are therefore: 1. To estimate the absolute and relative incidence rate (IR) of CVD claims-based diagnoses among a cohort of adult patients from a large managed care population with a claims diagnosis of HIV, AIDS, or AIDS-related complex (ARC) during periods of exposure to: - Any HAART compared to no HAART exposure - HAART class [i.e., NRTIs, NNRTIs, PIs, and Other (i.e., fusion inhibitors)] compared to no HAART class exposure - Specific NRTI medications compared to no specific NRTI exposure

NCT ID: NCT01051414 Completed - Clinical trials for Hepatitis C Infection

An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject

Start date: April 2010
Phase: Phase 2
Study type: Interventional

To assess the efficacy and safety profile of co-administration of BMS-790052 and BMS-650032 for 24 weeks treatment.

NCT ID: NCT01050608 Completed - Clinical trials for Nosocomial Infection

Evaluation of Body-worn Multimodal Hand Hygiene System. Impact on Health-Care Associated Infections

Sprixx-ICU
Start date: December 2007
Phase: N/A
Study type: Observational

Evaluate the efficacy of a multimodal hand hygiene system in the intensive care unit environment and evaluate any impact on health care associated infections.

NCT ID: NCT01050465 Completed - Obesity Clinical Trials

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

Start date: May 2009
Phase: N/A
Study type: Interventional

The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.

NCT ID: NCT01049971 Completed - Colorectal Surgery Clinical Trials

REDWIL: Reduction of Wound Infections in Laparoscopic Colon Resections by Wound Protectors

REDWIL
Start date: December 2007
Phase: N/A
Study type: Interventional

Surgical site infection is common in colorectal surgery leading to increased postoperative pain, longer hospital stay, delayed wound healing and increased re-operation rates. Hence, reducing the wound infection rate is a major aim in abdominal surgery. Wound protectors were invented for retracting the abdominal wall and keeping the abdominal wall sterile in order to reduce bacterial colonialization of the wound and wound infections. This is a prospective-randomized trial comparing use of wound protectors versus woven drapes in laparoscopic colon resections with minilaparotomy.

NCT ID: NCT01049438 Completed - Clinical trials for Methicillin Resistant Staphylococcus Aureus Skin Infections

A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections

Start date: August 2006
Phase: N/A
Study type: Interventional

This clinical trial tests the hypothesis that body decolonization of patients with recurrent community-associated (CA) MRSA infections will significantly reduce the likelihood of recurrent CA-MRSA infection.

NCT ID: NCT01046981 Completed - Clinical trials for Prevention of Surgical Site Infections

Tumescent Antibiotic Delivery Pharmacokinetics

Start date: March 2009
Phase: Phase 1
Study type: Interventional

Tumescent Antibiotic Delivery (TAD) is a technique for improving the prevention of surgical site infections (SSI). TAD involves the subcutaneous infiltration of tumescent local anesthesia (TLA) containing water soluble antibiotic(s) such as cefazolin and metronidazole. TLA consists of the subcutaneous infiltration of very dilute lidocaine (≤ 1 gram/liter) and epinephrine (≤ 1 milligram/liter) with sodium bicarbonate (10 milliequivalents/liter) in a physiologic solution of sodium chloride which produces intense local anesthesia associated with profound wide-spread vasoconstriction lasting for more than 12 hours. Compared to intravenous antibiotic delivery (IVAD), TAD is expected to produce higher local tissue concentrations of the antibiotic(s) for longer periods of time and lower systemic/serum antibiotic concentrations. This clinical trial will compare TAD to IVAD with respect to pharmacokinetic evidence for possible improved SSI prevention.